Skip to main content

Table 5 Secondary outcomes

From: Effect of postoperative goal-directed therapy in cancer patients undergoing high-risk surgery: a randomized clinical trial and meta-analysis

Variable

GDHT group

(n = 64)

Usual care group

(n = 64)

Absolute difference (95% CI)

p

Septic shock

16 (8–27)

13 (6–23)

3.1 (−9.3 to 15.5)

0.611

AKI AKIN 3 and RRT

13 (6–23)

8 (3–17)

4.7 (− 6.3 to 15.9)

0.380

ICU readmission

13 (6–23)

9 (4–19)

3.1 (− 8.2 to 14.6)

0.571

Length of ICU stay (days), median (IQR)

3 (2–8)

3 (2–5)

0.571

Length of hospital stay (days), median (IQR)

11 (6–19)

10 (6–15)

0.354

SOFA score, mean ± SD

   

0.308

 Admission

4.3 ± 2.4

3.6 ± 2.2

−0.7 (− 1.5 to 0.1)

 

 D1

4.0 ± 2.5

3.2 ± 2.3

− 0.8 (− 1.6 to 0)

 

 D2

2.8 ± 2.8

2.1 ± 2.2

− 0.7 (− 1.6 to 0.2)

 
  1. Data presented as % (95% CI)
  2. GDT goal-directed hemodynamic therapy, CI confidence interval, AKI acute kidney injury, AKIN Acute Kidney Injury Network, RRT renal replacement therapy, ICU intensive care unit, IQR interquartile range, SOFA Sequential Organ Failure Assessment, SD standard deviation, D1 first day postoperative, D2 second day postoperative